Palavale en es it fr

Palavale Brand names, Palavale Analogs

Palavale Brand Names Mixture

  • No information avaliable

Palavale Chemical_Formula


Palavale RX_link

Palavale fda sheet

Palavale FDA

Palavale msds (material safety sheet)

Palavale Synthesis Reference

No information avaliable

Palavale Molecular Weight

277.279 g/mol

Palavale Melting Point

No information avaliable

Palavale H2O Solubility

Slightly soluble (2.4 mg/mL at pH 7.9, 25oC)

Palavale State


Palavale LogP

No information avaliable

Palavale Dosage Forms

Film-coated tablets for oral administration (0.5 mg, 1 mg); Oral solution (0.05 mg/mL)

Palavale Indication

For the treatment of chronic hepatitis B virus infection in adults with evidence of active viral replication and either evidence of persistent elevations in serum aminotransferases (ALT or AST) or histologically active disease.

Palavale Pharmacology

Entecavir is a guanosine nucleoside analogue with selective activity against hepatitis B virus (HBV). It is designed to selectively inhibit the Hepatitis B virus, blocking all three steps in the replication process. Entecavir is more efficient than an older Hepatitis B drug, lamivudine.

Palavale Absorption

Absorption Following oral administration in healthy subjects, entecavir peak plasma concentrations occurred between 0.5 and 1.5 hours. In healthy subjects, the bioavailability of the tablet is 100% relative to the oral solution.

Palavale side effects and Toxicity

No information avaliable

Palavale Patient Information

Palavale Organisms Affected

Hepatitis B